First Step Program for Substance Use Disorders
A Preliminary Study on the Effectiveness of a Psychosocial Treatment Program (First Step Program) for Substance Use Disorders
1 other identifier
interventional
20
1 country
2
Brief Summary
This study examines whether a newly developed four-session psychosocial treatment program, called the First Step Program, can be delivered in real-world hospital settings to people receiving inpatient care for substance use disorders in Korea, and whether it shows early signs of benefit. The program combines motivational interviewing, acceptance and commitment therapy, and group activities, and is delivered twice a week over about two weeks (four 50-minute sessions). About 20 adults will take part at two psychiatric hospitals. Participants complete brief questionnaires and a short interview about their motivation to change, craving, engagement in valued living, and social support before the program, immediately before and after each session, within one week after the program ends, and again at 1 month and 3 months after completion. After the program, some participants also join a small group discussion (focus group interview) to share their experience of the program. Because this is a small, single-group preliminary (pilot) study without a comparison group, its primary purpose is to assess feasibility, that is, whether the program and the assessment approach work well enough, and to obtain preliminary effect and variability estimates to inform the design of a future large-scale randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2026
CompletedFirst Posted
Study publicly available on registry
June 22, 2026
CompletedStudy Start
First participant enrolled
June 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
June 22, 2026
June 1, 2026
6 months
June 9, 2026
June 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility: Program Completion (Retention) Rate
Proportion of enrolled participants who complete all four sessions of the First Step Program. Feasibility is further characterized by recruitment rate, session attendance, and assessment completion rates.
From enrollment through the end of the 4-session intervention (approximately 2 weeks)
Change in Motivation to Change (URICA-DO)
Motivation to change (readiness) measured by the Korean version of the University of Rhode Island Change Assessment for Drug Offenders (URICA-DO), a 24-item scale rated from 1 (strongly disagree) to 5 (strongly agree) with four subscales (Precontemplation, Contemplation, Action, Maintenance). A Readiness to Change score is computed as the sum of the mean Contemplation, Action, and Maintenance subscale scores minus the mean Precontemplation subscale score, yielding a range of -2 to 14; higher scores indicate greater readiness to change (better outcome).
Baseline (within 1 week before program), post-intervention (within 1 week after program), 1 month and 3 months after program completion
Secondary Outcomes (5)
Change in Craving (VAS-C)
Immediately before and immediately after each of the 4 sessions (over approximately 2 weeks); baseline (within 1 week before the program); within 1 week post-intervention; 1 month post-intervention; 3 months post-intervention
Change in Engaged Living (Engaged Living Scale, ELS)
Baseline, post-intervention (within 1 week), 1 month and 3 months after completion
Change in Social Support (2-Way Social Support Scale)
Baseline, post-intervention (within 1 week), 1 month and 3 months after completion
Change in Drug Use and Treatment Service Utilization
Baseline, post-intervention (within 1 week), 1 month and 3 months after completion
Program Acceptability (Focus Group Interview)
Within 1 week after program completion
Other Outcomes (3)
Stage of Change Rating per Session
Immediately after each of the 4 sessions (over approximately 2 weeks)
Session Satisfaction
Immediately after each of the 4 sessions
Treatment Fidelity (Adherence Rate)
Immediately after each of the 4 sessions
Study Arms (1)
First Step Program
EXPERIMENTALAll participants receive the First Step Program, a four-session group-based psychosocial treatment delivered twice weekly (50 minutes per session) over approximately two weeks. The program integrates motivational interviewing, acceptance and commitment therapy, and group therapy, covering values clarification, functional analysis of substance use, ambivalence and recovery-supporting relationships, and a personalized recovery plan.
Interventions
Four 50-minute group sessions delivered twice weekly over approximately two weeks. Session 1: treatment, choice, and personal values. Session 2: understanding the function of substance use and exploring alternative behaviors. Session 3: addressing ambivalence and recovery-supporting relationships. Session 4: charting a recovery direction and declaring a personal recovery plan. Core techniques are motivational interviewing, acceptance and commitment therapy, and group therapy.
Eligibility Criteria
You may qualify if:
- Adults aged 19 to 65 years who can understand the study purpose and procedures and provide written informed consent
- Currently hospitalized (inpatient)
- Able to communicate and complete questionnaires in Korean
- Physically able to participate in program activities
- Has completed detoxification treatment
- Meets indication thresholds: DAST-10 score \>= 2, URICA-DO precontemplation or contemplation stage, and \>= 2 DSM-5 criteria
You may not qualify if:
- Cognitive impairment that precludes communication
- Physical conditions that preclude program participation (e.g., musculoskeletal disorder, severe cardiopulmonary disease)
- Acute psychotic symptoms or risk of self-harm or harm to others
- At risk of disrupting group activities such that focus group participation is not feasible
- Individuals who are inmates or incarcerated at screening are not enrolled; participants who become incarcerated after enrollment are withdrawn
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Daegu Daedong Hospital
Daegu, South Korea
Incheon Chamsarang Hospital
Incheon, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hae Kook Lee, MD, PhD
The Catholic University of Korea
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 9, 2026
First Posted
June 22, 2026
Study Start
June 22, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
June 22, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
This is a small, single-group pilot study involving sensitive data from patients with substance use disorders. Given the limited sample size and re-identification risk, individual participant data will not be shared. Only de-identified, aggregated results will be reported.